{"id":8966,"date":"2025-10-21T09:23:51","date_gmt":"2025-10-21T06:23:51","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8966"},"modified":"2025-10-21T09:23:51","modified_gmt":"2025-10-21T06:23:51","slug":"acc-measure-hscrp-in-cvd-prevention-source-medscape-october-17-2025","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/acc-measure-hscrp-in-cvd-prevention-source-medscape-october-17-2025\/","title":{"rendered":"ACC: Measure hsCRP in CVD Prevention Source : Medscape, October 17, 2025"},"content":{"rendered":"<div>ACC: Measure hsCRP in CVD Prevention<\/div>\n<div>Source : Medscape, October 17, 2025<\/div>\n<div><\/div>\n<div>Keynotes:<\/div>\n<div><span> 1. New ACC statement recommends routine hsCRP testing for both primary and secondary heart disease prevention.<\/span><\/div>\n<div>Clinical Application:<\/div>\n<div><span> \u2022 Measure hsCRP along with LDL-C during routine risk assessment.<\/span><\/div>\n<div><span> \u2022 Use hsCRP results to:<\/span><\/div>\n<div><span> \u2022 Identify patients with high inflammatory risk<\/span><\/div>\n<div><\/div>\n<div><span> 2. hsCRP is as strong a predictor of future heart events as LDL cholesterol, even in patients on statins.<\/span><\/div>\n<div><span> 3. Other inflammatory markers (IL-6, fibrinogen, N\/L ratio) add little beyond hsCRP.<\/span><\/div>\n<div><span> 4. Doctors should measure hsCRP + LDL-C to detect hidden inflammation early.<\/span><\/div>\n<div><span> 5. Lifestyle measures to reduce inflammation: 150 min\/week exercise, Mediterranean or DASH diet, omega-3 intake.<\/span><\/div>\n<div><span> 6. Colchicine and other anti-inflammatory drugs may help high-risk patients.<\/span><\/div>\n<div><span> 7. Conclusion: Inflammation is now a treatable heart risk, and hsCRP should be part of routine care.<\/span><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/www.medscape.com\/viewarticle\/acc-measure-high-sensitivity-c-reactive-protein-cvd-2025a1000s7u\">https:\/\/www.medscape.com\/viewarticle\/acc-measure-high-sensitivity-c-reactive-protein-cvd-2025a1000s7u<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ACC: Measure hsCRP in CVD Prevention Source : Medscape, October 17, 2025 Keynotes: 1. New ACC statement recommends routine hsCRP testing for both primary and secondary heart disease prevention. Clinical Application: \u2022 Measure hsCRP along with LDL-C during routine risk assessment. \u2022 Use hsCRP results to: \u2022 Identify patients with high inflammatory risk 2. hsCRP [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8966","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8966"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8966\/revisions"}],"predecessor-version":[{"id":8967,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8966\/revisions\/8967"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}